Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
12 JPY
237.94 M JPY
4.36 B JPY
9.25 M
About CELLSOURCE CO LTD
Sector
Industry
CEO
Takashi Sawada
Website
Headquarters
Tokyo
Founded
2015
ISIN
JP3423580004
FIGI
BBG00Q9X6X65
CellSource Co., Ltd. engages in regenerative medicine related business. Its business includes fat, blood-derived tissue and cell processing service. It also offers regenerative medicine legal support service, sale of medical device, cosmetics and facial products. It operates through the Regenerative Medicine-related business segments. The Regenerative Medicine-related segment handles stem cell processing contract service, blood derived processing contract service and consulting service. It also sells equipment necessary for medical institutions to collect fat from patients. The company was founded on November 30, 2015 and is headquartered in Tokyo, Japan.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of 4880 is 798 JPY — it has decreased by −2.47% in the past 24 hours. Watch CELLSOURCE CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange CELLSOURCE CO LTD stocks are traded under the ticker 4880.
4880 stock has fallen by −4.13% compared to the previous week, the month change is a −9.51% fall, over the last year CELLSOURCE CO LTD has showed a −46.76% decrease.
We've gathered analysts' opinions on CELLSOURCE CO LTD future price: according to them, 4880 price has a max estimate of 910.00 JPY and a min estimate of 910.00 JPY. Watch 4880 chart and read a more detailed CELLSOURCE CO LTD stock forecast: see what analysts think of CELLSOURCE CO LTD and suggest that you do with its stocks.
4880 reached its all-time high on Dec 9, 2021 with the price of 8,160 JPY, and its all-time low was 611 JPY and was reached on Oct 29, 2019. View more price dynamics on 4880 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4880 stock is 3.58% volatile and has beta coefficient of 0.51. Track CELLSOURCE CO LTD stock price on the chart and check out the list of the most volatile stocks — is CELLSOURCE CO LTD there?
Today CELLSOURCE CO LTD has the market capitalization of 15.93 B, it has decreased by −2.63% over the last week.
Yes, you can track CELLSOURCE CO LTD financials in yearly and quarterly reports right on TradingView.
CELLSOURCE CO LTD is going to release the next earnings report on Mar 11, 2025. Keep track of upcoming events with our Earnings Calendar.
CELLSOURCE CO LTD revenue for the last quarter amounts to 1.01 B JPY, despite the estimated figure of 1.03 B JPY. In the next quarter, revenue is expected to reach 1.04 B JPY.
4880 net income for the last quarter is −136.27 M JPY, while the quarter before that showed 74.23 M JPY of net income which accounts for −283.57% change. Track more CELLSOURCE CO LTD financial stats to get the full picture.
CELLSOURCE CO LTD dividend yield was 0.42% in 2024, and payout ratio reached 41.61%. The year before the numbers were 1.12% and 40.91% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Mar 11, 2025, the company has 157.00 employees. See our rating of the largest employees — is CELLSOURCE CO LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CELLSOURCE CO LTD EBITDA is 271.16 M JPY, and current EBITDA margin is 6.48%. See more stats in CELLSOURCE CO LTD financial statements.
Like other stocks, 4880 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CELLSOURCE CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CELLSOURCE CO LTD technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CELLSOURCE CO LTD stock shows the sell signal. See more of CELLSOURCE CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.